The patient voice in clinical trial research Canadian Cancer Trials Group (CCTG) recognizes the value and importance of engaging patients, including the patient voice in all aspects of the clinical trial life-cycle. Integrating the patient perspective into the CCTG’s overall strategic agenda ensures the research agenda has the greatest impact on cancer patients in Canada and around the world.CCTG has implemented a model of dedicated public and patient involvement by including the Patient Representative, who are patient volunteers recruited to disease site committees similar to academic committee members with a three year extendable term.The role of the CCTG Patient Representative has evolved to integrate the patient perspective into many steps of the research process with the aim of:research questions that matter to patients, andimproved accrualCCTG is committed to implementing best practices and materials to foster and facilitate patient engagementIf you are looking for more information about the CCTG Patient Representative Committee please contact Yvonne Murray, Patient Engagement Lead for information.CCTG is currently looking for volunteers for these roles:To support the Hematology Disease Site Committee | en françaisTo support the Breast Disease Site Committee | en français To support the Genito-Urinary Disease Site Committee | en françaisTo support the Investigational New Drug (IND) Program | en francaisFor more information about current committee openings please contact Nancy Dusharm.CCTG Patient Representative CommitteeJudy Needham - Patient Representative ChairBob TaylorCarol GordonDavid McMullenErwin WandererJanice HodgsonJoan PetrieHilary HorlockCatherine WrefordMarie-Térèse LittleMartina Wood Emi BossioMarg RedlickBill RichardsonLouise BirdJasmine HeuringHaydn BechtholdSuzanne Wood